Article Details

Covaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs ...

Retrieved on: 2021-10-12 09:21:36

Tags for this article:

Click the tags to see associated articles and topics

Covaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs .... View article details on hiswai:

Excerpt

Subject Expert Committee has approved Bharat Biotech's covid vaccine 'COVAXIN' for children in the 2-18 age group. DCGI will now to take the final call.

Article found on: m.economictimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up